Encompass Health CorpEHC
Price$119.06Intrinsic value$115.693% below price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $115.69median of 6 methods · middle span $94-$150based on filings through 30 Jun 2026
Market Price $119.06Price as of 1 Oct 2026
Margin of Safety -2.8%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 12.7% (near-term consensus, capped) · years 2–5: 9.4%/yr (balance of the path).10.1% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 69.5%Yr 79.5%Yr 89.5%Yr 99.5%Yr 109.5%
9.4% → 9.5%
Years 11–20: glide to long-run rate
Per-year rates
Yr 118.9%Yr 128.2%Yr 137.6%Yr 146.9%Yr 156.3%Yr 165.6%Yr 175.0%Yr 184.3%Yr 193.7%Yr 203.0%
9.5% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 3 windows (5/6/7y)9.5%
Discount rate (cost of equity) 8.7%
Volatility vs market (adjusted beta)0.83

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetEncompass Health CorpEHCHealth Care
Valuation
P/E19.4×
P/S2.0×
P/B4.8×
EV / Revenue2.4×
EV / EBITDA8.8×
Profitability
Gross margin100.0%
Operating margin20.3%
Net margin10.0%
FCF margin6.7%
Returns
ROE23.9%
ROA8.3%
ROIC12.2%
Growth
Revenue growth (YoY)15.5%
5-yr fwd EPS growth10.1%
Financial strength
Debt / Equity1.00×
Current ratio1.19×
Altman Z-Score3.4
Interest coverage—
Dividend yield0.5%

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.